Corvus Pharmaceuticals Long Term Deferred Charges (Quarterly) Analysis

Corvus Pharmaceuticals, Inc. (CRVS)

16.57 -0.96 (-5.48%) USD | NASDAQ | Feb 20, 16:00

16.53 -0.04 (-0.24%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for CRVS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	--
Plus Therapeutics, Inc.	--
Geron Corp.	--
Jaguar Health, Inc.	--
Krystal Biotech, Inc.	--